AEP-8587

N/A

Report date: 2025/01/26 16:01:53

Base Information

Drug NameAEP-8587
Drug Alias Nameanti-GRP78 antibody (Amgen Research/McMaster University)AEP-8587
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of Action78 kDa glucose-regulated protein inhibitors
Targets78 kDa glucose-regulated protein
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesMcmaster UniversityAmgen Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A